Delivery Order SPE2DB24D1205-SPE2DB25FCRNF
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,416.19, is a delivery order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,588.45, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $51,106.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BIMZELX 160 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of June 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $9,783.88 and a completion date of May 22, 2025. The contract is not set aside and is for open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $25,549.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication BIMZELX 160 MG/ML AUTOINJECTORML, with a performance period ending on May 2, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,016.42 firm-fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,366.55 Firm Fixed Price Delivery Order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,791.12, is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR ML, a specialty medication. The contract has a firm fixed-price pricing structure and an ultimate completion date of October 11, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,312.33 firm fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through July 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,476.69, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of June 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite...